Skip to content

All recalls FDA

FDADrugsRecalled Status: Ongoing

Baxter Healthcare Corporation recalls Vancomycin Injection

Class IIofficial

FDA Class II

FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.

Hazard
CGMP Deviations
Products
  • Vancomycin Injection
Where it was sold

US Nationwide; Puerto Rico; and Chile.

Nationwide

Units affected
N/A
About this recall
Vancomycin Injection, USP in 5% Dextrose, 1 g per 200mL (5 mg/mL), in GALAXY Single-Dose Container, Rx only, Sterile Nonpyrogenic, Iso-osmotic, Baxter Healthcare Corporation, Deerfield, IL, 60015 USA, NDC 0338-3552-48.